Homebuilders ETF? T...
Health Care: Drugs
Par Pharmaceutical Companies Inc. (PRX: NYSE)
$36.34 -0.71 | -1.92%
02/10/12 - 10:29 AM ET
27.67K / 412.70K
Vol / Avg. Vol:36.70 / 37.05
Open / Prev. Close:36.15 - 36.70
Today's Range:24.85 - 38.85
52 Wk Range:13.66%
Performance YTD:TheStreet Rating:
Portfolios with PRX
- Portfolio NameUser Type
- Contributor8 Pharma Stocks to Watch
- Contributor10 Health Care Stocks With ...
- Contributor10 Pharma Stocks With Upside
- ProBridgeway Micro-Cap Limited...
- UserBlue Star
- UserDavid Maxwell Portfolio 1
- UserPART 6 JPMorgan 28th Annual...
- UserMillion Contrarian
- Userkern44 Portfolio 1
- UserSUPRATRADE-0303071618
Latest PRX Headlines from TheStreet
- Par Pharmaceutical Companies Reaches New 52-Week High (PRX) 02.01.12 | 02:02 pm
- UBS: 8 Pharma Stocks to Watch 01.20.12 | 12:01 pm
- Par Pharmaceutical Companies Stock Hits New 52-Week High (PRX) 01.19.12 | 01:01 pm
- Par Pharmaceutical Companies Inc. Stock Upgraded (PRX) 01.13.12 | 06:01 am
- Par Pharmaceutical Companies Stock Hits New 52-Week Low (PRX) 09.22.11 | 12:09 pm
- Par Pharmaceutical Companies Stock Hits New 52-Week Low (PRX) 09.06.11 | 03:09 pm
- Par Pharma to Buy Generics Rival Anchen 08.24.11 | 08:08 am
- Par Pharmaceuticals: Buried in Generic-Drugs Battlefield 05.12.11 | 12:05 pm
- Par Pharmaceutical Companies Inc. Stock Downgraded (PRX) 05.09.11 | 08:05 am
- Par 3Q Profit Surges On Product Sales 11.06.09 | 09:11 am
Press Releases for PRX
- Par Pharmaceutical Companies To Report Fourth Quarter And Full Year 2011 Results On February 28, 2012 - PR Newswire 01.31.12 | 09:01 am
- Par Pharmaceutical To Host Analyst Day On January 6, 2012 - PR Newswire 12.05.11 | 09:12 am
- Par Pharmaceutical Companies Promotes Thomas J. Haughey To President And Paul V. Campanelli To Chief Operating Officer - PR Newswire 11.22.11 | 08:11 am
- Par Pharmaceutical Completes Acquisition Of Anchen - PR Newswire 11.17.11 | 12:11 pm
- Par Pharmaceutical Begins Shipment Of Generic Zyprexa® Zydis® - PR Newswire 10.24.11 | 03:10 pm
- Par Pharmaceutical Acquires Three Generic Products From Teva Pharmaceuticals - PR Newswire 10.18.11 | 09:10 am
- Par Pharmaceutical Files Declaratory Judgment To Protect First Amendment Rights To Disseminate Truthful Information Regarding Megace® ES - PR Newswire 10.14.11 | 04:10 pm
- Par Pharmaceutical Companies To Report Third Quarter 2011 Results On November 2, 2011 - PR Newswire 10.03.11 | 04:10 pm
- MonoSol Rx Announces Availability Of Zuplenz® Oral Soluble Film For Licensing To New Commercialization Partners - PR Newswire 07.11.11 | 08:07 am
- Par Pharmaceutical Companies Announces A Restructuring Of Its Branded Division, Strativa Pharmaceuticals, To Maximize Profitability - PR Newswire 06.29.11 | 11:06 am
Partner Headlines for PRX
- EPS, Revenues Decline at Par Pharma - Analyst Blog - Zacks 11.04.11 | 04:11 pm
- Company News for October 21, 2011 - Corporate Summary - Zacks 10.21.11 | 10:10 am
- Stocks Rebound, Trade Higher Amid Mixed Slate of Earnings; China Data Weighs - NASDAQ 10.18.11 | 04:10 pm
- Mid-Day Update: Stocks Shift Higher After Mixed Start; China, Earnings Weigh - NASDAQ 10.18.11 | 04:10 pm
- Par Pharmaceutical Files Declaratory Judgment to Protect First Amendment Rights to Disseminate Truthful Information Regarding Megace® ES - Benzinga 10.14.11 | 04:10 pm
- Emisphere: Crown Jewel In Oral B12 - Seeking Alpha 10.07.11 | 09:10 am
- Par Pharma Targets Anchen Pharma - Analyst Blog - Zacks 08.25.11 | 10:08 am
- Par Pharma, IPCI Expand Deal - Analyst Blog - Zacks 08.19.11 | 03:08 pm
- Lower Spending Boosts Par Pharma - Analyst Blog - Zacks 08.05.11 | 04:08 pm
- PRX' Branded Business Faces Setback - Analyst Blog - Zacks 07.13.11 | 10:07 am
